{"id":41234,"date":"2026-10-07T15:30:26","date_gmt":"2026-10-07T14:30:26","guid":{"rendered":"https:\/\/faus-moliner.com\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/"},"modified":"2026-10-07T15:45:27","modified_gmt":"2026-10-07T14:45:27","slug":"limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/","title":{"rendered":"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante"},"content":{"rendered":"\n

Spanish courts with jurisdiction over European Union trademarks have recently issued several rulings addressing the limits on the use of third-party trademarks in the context of parallel imports of medicinal productos. This article reviews the case law of the CJEU on the matter and analyzes how recent Spanish decisions have rigorously applied this jurisprudential framework, strengthening the protection of medicinal products trademark holders against conduct that exceeds the limits of lawful parallel trade.<\/p>\n","protected":false},"excerpt":{"rendered":"

Spanish courts with jurisdiction over European Union trademarks have recently issued several rulings addressing the limits on the use of third-party trademarks in the context of parallel imports of medicinal productos. This article reviews the case law of the CJEU on the matter and analyzes how recent Spanish decisions have rigorously applied this jurisprudential framework,… <\/p>\n

<\/div>\n

Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[71,223],"tags":[],"coauthors":[106,523,526],"class_list":["post-41234","post","type-post","status-publish","format-standard","hentry","category-publications","category-regulatory-2"],"acf":[],"yoast_head":"\nL\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"Spanish courts with jurisdiction over European Union trademarks have recently issued several rulings addressing the limits on the use of third-party trademarks in the context of parallel imports of medicinal productos. This article reviews the case law of the CJEU on the matter and analyzes how recent Spanish decisions have rigorously applied this jurisprudential framework,... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-07T14:30:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-07T14:45:27+00:00\" \/>\n<meta name=\"author\" content=\"Faus Moliner, Claudia Gonzalo, Juan Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Faus Moliner, Claudia Gonzalo, Juan Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\\\/\"},\"author\":{\"name\":\"Faus Moliner\",\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/#\\\/schema\\\/person\\\/b62ac2c67efed1b6f50872c1d6366f90\"},\"headline\":\"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante\",\"datePublished\":\"2026-10-07T14:30:26+00:00\",\"dateModified\":\"2026-10-07T14:45:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\\\/\"},\"wordCount\":101,\"publisher\":{\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/#organization\"},\"articleSection\":[\"Publications\",\"Regulatory\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\\\/\",\"url\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\\\/\",\"name\":\"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/#website\"},\"datePublished\":\"2026-10-07T14:30:26+00:00\",\"dateModified\":\"2026-10-07T14:45:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/faus-moliner.com\\\/en\\\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/faus-moliner.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\\\/\\\/faus-moliner.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/2372042\\\/admin\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/#\\\/schema\\\/person\\\/b62ac2c67efed1b6f50872c1d6366f90\",\"name\":\"Faus Moliner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g88610ef99b0aa1c93ca33c569a053dac\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g\",\"caption\":\"Faus Moliner\"},\"url\":\"https:\\\/\\\/faus-moliner.com\\\/en\\\/author\\\/moon\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/","og_locale":"en_US","og_type":"article","og_title":"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante - Faus Moliner","og_description":"Spanish courts with jurisdiction over European Union trademarks have recently issued several rulings addressing the limits on the use of third-party trademarks in the context of parallel imports of medicinal productos. This article reviews the case law of the CJEU on the matter and analyzes how recent Spanish decisions have rigorously applied this jurisprudential framework,... Read More","og_url":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/","og_site_name":"Faus Moliner","article_published_time":"2026-10-07T14:30:26+00:00","article_modified_time":"2026-10-07T14:45:27+00:00","author":"Faus Moliner, Claudia Gonzalo, Juan Mart\u00ednez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Faus Moliner, Claudia Gonzalo, Juan Mart\u00ednez","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/"},"author":{"name":"Faus Moliner","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90"},"headline":"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante","datePublished":"2026-10-07T14:30:26+00:00","dateModified":"2026-10-07T14:45:27+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/"},"wordCount":101,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"articleSection":["Publications","Regulatory"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/","url":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/","name":"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"datePublished":"2026-10-07T14:30:26+00:00","dateModified":"2026-10-07T14:45:27+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/en\/limites-al-uso-de-marcas-ajenas-en-el-comercio-paralelo-de-medicamentos-las-recientes-decisiones-de-los-tribunales-de-marca-de-la-union-europea-de-alicante\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/en\/"},{"@type":"ListItem","position":2,"name":"L\u00edmites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la uni\u00f3n europea de alicante"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90","name":"Faus Moliner","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g88610ef99b0aa1c93ca33c569a053dac","url":"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g","caption":"Faus Moliner"},"url":"https:\/\/faus-moliner.com\/en\/author\/moon\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/41234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/comments?post=41234"}],"version-history":[{"count":2,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/41234\/revisions"}],"predecessor-version":[{"id":41239,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/41234\/revisions\/41239"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/media?parent=41234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/categories?post=41234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/tags?post=41234"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/coauthors?post=41234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}